Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection
AssigneeRobarts Research Institute
InventorsGrant McFadden, John C. Bell
Life of this patent
Estimating the term…
Abstract
The present invention relates to therapeutic use of Myxoma virus. Myxoma virus can selectively infect cells that have a deficient innate anti-viral response, including cells that are not responsive to interferon and can be used to treat diseases characterized by the presence of such cells, including cancer.
Claims20
A method for inhibiting a cell that has a deficient innate anti-viral response comprising administering to the cell an effective amount of Myxoma virus, wherein the cell is a mammalian cancer cell.
A method for treating a disease state characterized by the presence of cells that have a deficient innate anti-viral response, comprising administering to a patient in need thereof an effective amount of Myxoma virus, wherein the disease state is cancer, and wherein Myxoma virus inhibits cancer cells.
A kit comprising Myxoma virus and instructions for treating cancer in a patient in need thereof.
Dependencies are inferred from the claim text.